The Global Health EDCTP3 partnership launched a call for expression of interest for the selection of members of its Scientific Committee. Established in 2021, the Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking aims at delivering new solutions to reduce the burden of infectious diseases in sub-Saharan Africa and at strengthening research capacities to prepare and respond to re-emerging infectious diseases. The governance of Global Health EDCTP3 is led by a Governing Board which is advised by a Scientific Committee and a Stakeholders Group.
Candidate members should have proven competence and expertise in areas such as
- Product development and clinical research in infectious diseases affecting sub-Saharan Africa including HIV, tuberculosis, malaria, neglected infectious diseases, lower respiratory tract infections, diarrhoeal diseases, emerging and re-emerging infections, antimicrobial resistance as well as related co-morbidities.
- Epidemic preparedness research and response.
- Early warning, risk assessment and surveillance of emerging infectious diseases, climate crisis-related infectious disease and antimicrobial resistance.
- Deadline for applications is 30 September 2024, 23:59 (CET).
https://globalhealth-edctp3.eu/resources/open-call-expressions-interest-scientific-committee